Mirae Asset Global Investments Co., Ltd. Repligen Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 29,522 shares of RGEN stock, worth $4.56 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,522
Previous 29,822
1.01%
Holding current value
$4.56 Million
Previous $3.79 Million
3.24%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding RGEN
# of Institutions
507Shares Held
58.9MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.17 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$1.02 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$785 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$296 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$251 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.58B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....